Eric Johnson is a Psychiatry physician. ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
202 N 24th Ave E
Duluth, MN 558121859
Telephone
320-983-5728Provider last certified this registry record 2 Jan 2020.
Clinical trials
- Immediate Effect of Ankle Mobilization on Active Range of Motion and Gait in Subacute Stroke
Sponsor: Loma Linda University
- Effects of Electrotherapy on Pain, Anxiety, Motion and Disability in Adults With Neck or Upper Body Pain.
Sponsor: Loma Linda University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Brainsway USA INCProgram year20231 payment
- Teva Pharmaceuticals USA, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
93.9%Atypical Antipsychotic18.9%Quetiapine Fumarate30%Olanzapine19%Aripiprazole16%Risperidone13%Clozapine11%Lurasidone Hcl4%Invega Sustenna3%Ziprasidone Hcl1%Abilify Maintena1%Latuda1%Clozapine Odt1%Perseris1%Part D<11 patientsSSRI14.2%Trazodone Hcl33%Sertraline Hcl25%Escitalopram Oxalate15%Fluoxetine Hcl12%Citalopram Hbr6%Paroxetine Hcl6%Fluvoxamine Maleate2%Part D<11 patients+ 30 more classes in this area
Cardiovascular
4.7%alpha-Adrenergic Blocker2.5%Prazosin Hcl100%Part D≥46 patientsBeta blocker1.1%Propranolol Hcl65%Propranolol Hcl Er24%Metoprolol Succinate11%Part D<11 patients+ 1 more class in this area
Respiratory
0.6%Other antihistamines for systemic use0.6%Cyproheptadine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1995–1996 per NIH RePORTER. The latest:
- UNIQUE MODEL FOR THE STUDY OF XENOGRAFT REJECTION
University of Minnesota Twin Cities
FY1996F32DK009258 - UNIQUE MODEL FOR THE STUDY OF XENOGRAFT REJECTION
University of Minnesota Twin Cities
FY1995F32DK009258
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”